Whole-body CT reduces trauma-related deaths
Seriously injured patients have a better chance of surviving multiple trauma when they are evaluated in the emergency room with whole-body CT, according to a study of more than 4500 cases from Germany.
Seriously injured patients have a better chance of surviving multiple trauma when they are evaluated in the emergency room with whole-body CT, according to a study of more than 4500 cases from Germany.
Dr. Stefan Huber-Wagner and colleagues at the Munich University Hospital's department of trauma surgery compared the probability of survival in patients with blunt multiple trauma who underwent whole-body CT during resuscitation with those who did not. The investigators reviewed data from 4621 patients from several trauma centers recorded by the German Trauma Society’s registry. Using two different standard injury assessment methods, they found that polytrauma patients who underwent whole-body scans could achieve up to a 25% lower mortality risk than those who did not undergo whole-body CT. The researchers published results in the April 25 issue of The Lancet.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
